Michael T Longaker

This inventor holds 29 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Tissue Regeneration. Top assignees: Leland Stanford Junior University, Neodyne Biosciences, Inc.. Active years: 2010-2026.

USPTO Granted Patents = 29 (Patent Applications = 15)

% Patents Active = 89.7

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 4.5

ph-index = 9

Forward Citations = 328(Granted Patents)

Location History:

Stanford, CA (US) (2015 - 2017)
Atherton, CA (US) (2010 - 2023)

Company Filing History:

25 out of 5,509

Leland Stanford Junior University

patents

4 out of 22

Neodyne Biosciences, Inc.

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Cartilage Regeneration

Scar Prevention

Skin Treatment Devices

Stem Cells

Vascularity

Fibrotic Tissue

Progenitor Cells

Radiation Therapy

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12691161 - Mechanical and biochemical activation and control of skeletal stem cells for cartilage regeneration (2026-07-28),

2. 12673043 - Use of inhibitors of the activator protein 1 (AP-1) for preventing adhesions (2026-07-07),

3. 12570763 - AEROSOLIZED MUCUS-TETHERING NANOBODIES TO PROTECT AGAINST VIRAL AND MICROBIAL CONTAMINATION IN CLOSED AND SEMI-ENCLOSED SPACES (2026-03-10),

4. 12403106 - Prophylactic skin treatment for radiation therapy (2025-09-02),

5. 12303475 - Conditioning irradiated tissue for increasing vascularity (2025-05-20),

6. 12236599 - Systems and methods for analyzing, detecting, and treating fibrotic connective tissue network formation (2025-02-25),

7. 11701262 - Devices and methods for skin tightening (2023-07-18),

8. 11529391 - Reversing deficient hedgehog signaling restores deficient skeletal regeneration (2022-12-20),

9. 11369641 - Identification and uses of vasculature forming progenitor cells and progenitor cell combinations (2022-06-28),

10. 11331288 - Conditioning irradiated tissue for increasing vascularity (2022-05-17),

11. 11246763 - Skin treatment devices and methods with pre-stressed configurations (2022-02-15),

12. 11083755 - Factors and cells that provide for induction of bone, bone marrow, and cartilage (2021-08-10),

13. 10857037 - Controlled strain skin treatment devices and methods (2020-12-08),

14. 10561359 - Elastic devices, methods, systems and kits for selecting skin treatment devices (2020-02-18),

15. 9889046 - Skin treatment devices and methods with pre-stressed configurations (2018-02-13),

Title: Inventor Michael T. Longaker - Pioneering Innovations in Medicine

Introduction: Michael T. Longaker is a distinguished inventor known for his groundbreaking contributions to the field of medicine, particularly in the realm of regenerative medicine and tissue engineering.

Latest Patents: Michael T. Longaker holds several patents related to novel surgical techniques, advanced wound healing technologies, and innovative approaches to tissue regeneration.

Career Highlights: With a career spanning several decades, Michael T. Longaker has held prominent positions at renowned research institutions and universities, where he has led pioneering research projects and mentored numerous aspiring scientists.

Collaborations: Throughout his career, Michael T. Longaker has collaborated with leading experts in various disciplines, fostering a culture of innovation and interdisciplinary research that has resulted in significant advancements in the field of medicine.

Conclusion: Michael T. Longaker's relentless pursuit of innovation and his commitment to pushing the boundaries of medical science have solidified his reputation as a visionary inventor whose work continues to inspire and shape the future of regenerative medicine.